InterCore Energy, Inc. Announces Exclusive Distribution Agreement with MeliaLife International Inc.

Mar 18, 2013, 10:50 ET from InterCore Energy, Inc.

MAHWAH, N.J., March 18, 2013 /PRNewswire/ -- InterCore Energy, Inc (OTCQB: ICOR), a holding company with planned operations in various business sectors, announced entering into an exclusive five-year international distribution agreement with MeliaLife International Inc., a leading manufacturer of unique liquid nutritional supplements.  These products will be marketed through InterPharma, LLC, a newly formed subsidiary focused upon health and wellness solutions.  Terms of the agreement call for InterCore to acquire all rights to such products at the end of the five-year period through the payment to MeliaLife of an aggregate of $30 million over the life of the agreement.

MeliaLife's new generation of natural supplements include high quality liquid products manufactured from plants in Asia, Europe, and South America.  The effectiveness of the extracts and liquid formulations are all laboratory-tested by a team of researchers and biochemists.  These carefully developed products are considered to be "The Great Vintage" of natural nutritional supplements today.  MeliaLife's state-of-the-art extraction methods and special processing techniques allows its product line to preserve all their nutritional properties.  MeliaLife optimizes their biological effect on organisms, according to very rigid quality standards, in addition to assuring there are no transformations in and no substitutions for the herbs that we use.

"We are very much looking forward to having InterCore as our exclusive distributor," said Yves Tremblay, Founder and President of MeliaLife International. "This agreement provides MeliaLife with the opportunity to expand our resources and products to a broader customer base.  Through InterPharma's sales force, network of distribution channels and steadfast commitment to both product availability and international reach, we anticipate positive future results in our sales."

Commenting on the agreement, Claude Brun, Chief Executive Officer of InterCore Energy stated, "As we begin to expand our global operations and holdings, we have committed many of our resources to support this agreement and expect to not only meet but exceed sales targets which will allow us to purchase the business from MeliaLife with little or no further infusion of capital.  MeliaLife's product line includes Betterflex, MenoMelia, Prostamune, Calcium Cynergy, Cholesterol Solutions, among many more needed and required specialized nutritional supplements, all of which we believe can be marketed and sold throughout the world."

About InterCore Energy, Inc.

As a result of the transaction described above, ICOR will focus on development and marketing of the ADS Software and related products.  

InterCore Energy, Inc. ("ICOR") operates in two distinct business sectors through the following wholly-owned subsidiaries:

  • INTERPHARMA, LLC is the worldwide exclusive distributor of MeliaLife International products.
  • SRG, Inc. is a technology company that owns Alertness Detection Software(ADS™), a system of proprietary alertness detection technologies, which alerts operators of, for example, vehicles and machinery where safety is critical, to their capabilities based on real time monitoring of their state of alertness.

Forward Looking Statements. This news release contains certain "forward-looking statements." Forward-looking statements are based on current expectations and assumptions and are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified, and many of which are beyond the Company's control. The forward-looking statements are also identified through the use of words "believe", "enable," "may," "will," "could," "intends," "estimate," "anticipate," "plan," "predict" "probable," "potential," "possible," "should," "continue," and other words of similar meaning. Actual results could differ materially from these forward-looking statements as a result of a number of risk factors detailed in the Company's periodic reports filed with the U.S. Securities and Exchange Commission via the Edgar system. Given these risks and uncertainties, investors are cautioned not to place undue reliance on such forward-looking statements and no assurances can be given that such statements will be achieved.

For additional information visit

For additional information regarding MeliaLife International and the products, visit

Investor Relations Contact
Andrew Barwicki
516-662-9461 /

SOURCE InterCore Energy, Inc.